123 related articles for article (PubMed ID: 31562641)
21. miR-582-3p and miR-582-5p Suppress Prostate Cancer Metastasis to Bone by Repressing TGF-β Signaling.
Huang S; Zou C; Tang Y; Wa Q; Peng X; Chen X; Yang C; Ren D; Huang Y; Liao Z; Huang S; Zou X; Pan J
Mol Ther Nucleic Acids; 2019 Jun; 16():91-104. PubMed ID: 30852380
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of miR‑19a‑3p promotes invasion, migration and bone metastasis via activating TGF‑β signaling in prostate cancer.
Wa Q; Li L; Lin H; Peng X; Ren D; Huang Y; He P; Huang S
Oncol Rep; 2018 Jan; 39(1):81-90. PubMed ID: 29138858
[TBL] [Abstract][Full Text] [Related]
23. Tumor-derived miR-378a-3p-containing extracellular vesicles promote osteolysis by activating the Dyrk1a/Nfatc1/Angptl2 axis for bone metastasis.
Wang J; Du X; Wang X; Xiao H; Jing N; Xue W; Dong B; Gao WQ; Fang YX
Cancer Lett; 2022 Feb; 526():76-90. PubMed ID: 34801597
[TBL] [Abstract][Full Text] [Related]
24. MAZ promotes prostate cancer bone metastasis through transcriptionally activating the KRas-dependent RalGEFs pathway.
Yang Q; Lang C; Wu Z; Dai Y; He S; Guo W; Huang S; Du H; Ren D; Peng X
J Exp Clin Cancer Res; 2019 Sep; 38(1):391. PubMed ID: 31488180
[TBL] [Abstract][Full Text] [Related]
25. A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting
Ramalho-Carvalho J; Gonçalves CS; Graça I; Bidarra D; Pereira-Silva E; Salta S; Godinho MI; Gomez A; Esteller M; Costa BM; Henrique R; Jerónimo C
Clin Epigenetics; 2018; 10():40. PubMed ID: 29599847
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-455-3p functions as a tumor suppressor by targeting eIF4E in prostate cancer.
Zhao Y; Yan M; Yun Y; Zhang J; Zhang R; Li Y; Wu X; Liu Q; Miao W; Jiang H
Oncol Rep; 2017 Apr; 37(4):2449-2458. PubMed ID: 28350134
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-223-3p regulates cell chemo-sensitivity by targeting FOXO3 in prostatic cancer.
Feng Q; He P; Wang Y
Gene; 2018 Jun; 658():152-158. PubMed ID: 29518547
[TBL] [Abstract][Full Text] [Related]
28. miR-490-3p modulates the progression of prostate cancer through regulating histone deacetylase 2.
Fan H; Zhang YS
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):539-546. PubMed ID: 30720161
[TBL] [Abstract][Full Text] [Related]
29. MiR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition.
Wang L; Song G; Tan W; Qi M; Zhang L; Chan J; Yu J; Han J; Han B
Oncotarget; 2015 Nov; 6(34):35978-90. PubMed ID: 26451614
[TBL] [Abstract][Full Text] [Related]
30. Decreased miR-218-5p Levels as a Serum Biomarker in Bone Metastasis of Prostate Cancer.
Peng P; Chen T; Wang Q; Zhang Y; Zheng F; Huang S; Tang Y; Yang C; Ding W; Ren D; Huang Z; Guo Y
Oncol Res Treat; 2019; 42(4):165-185. PubMed ID: 30870834
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia induced microRNA-301b-3p overexpression promotes proliferation, migration and invasion of prostate cancer cells by targeting LRP1B.
Zheng H; Bai L
Exp Mol Pathol; 2019 Dec; 111():104301. PubMed ID: 31442444
[TBL] [Abstract][Full Text] [Related]
32. MiRNA-296-3p-ICAM-1 axis promotes metastasis of prostate cancer by possible enhancing survival of natural killer cell-resistant circulating tumour cells.
Liu X; Chen Q; Yan J; Wang Y; Zhu C; Chen C; Zhao X; Xu M; Sun Q; Deng R; Zhang H; Qu Y; Huang J; Jiang B; Yu J
Cell Death Dis; 2013 Nov; 4(11):e928. PubMed ID: 24263102
[TBL] [Abstract][Full Text] [Related]
33. miR-129-3p controls centrosome number in metastatic prostate cancer cells by repressing CP110.
Bijnsdorp IV; Hodzic J; Lagerweij T; Westerman B; Krijgsman O; Broeke J; Verweij F; Nilsson RJ; Rozendaal L; van Beusechem VW; van Moorselaar JA; Wurdinger T; Geldof AA
Oncotarget; 2016 Mar; 7(13):16676-87. PubMed ID: 26918338
[TBL] [Abstract][Full Text] [Related]
34. Loss of MicroRNA-489-3p promotes osteosarcoma metastasis by activating PAX3-MET pathway.
Liu Q; Yang G; Qian Y
Mol Carcinog; 2017 Apr; 56(4):1312-1321. PubMed ID: 27859625
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of miR‑505‑3p predicts poor bone metastasis‑free survival in prostate cancer.
Tang Y; Wu B; Huang S; Peng X; Li X; Huang X; Zhou W; Xie P; He P
Oncol Rep; 2019 Jan; 41(1):57-66. PubMed ID: 30365141
[TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor receptor signaling promotes metastatic prostate cancer through microRNA-96-mediated downregulation of the tumor suppressor ETV6.
Tsai YC; Chen WY; Siu MK; Tsai HY; Yin JJ; Huang J; Liu YN
Cancer Lett; 2017 Jan; 384():1-8. PubMed ID: 27746161
[TBL] [Abstract][Full Text] [Related]
37. Ectopic Expression of miR-532-3p Suppresses Bone Metastasis of Prostate Cancer Cells via Inactivating NF-κB Signaling.
Wa Q; Zou C; Lin Z; Huang S; Peng X; Yang C; Ren D; Xu D; Guo Y; Liao Z; Wang B; Hu H; Huang S; He P
Mol Ther Oncolytics; 2020 Jun; 17():267-277. PubMed ID: 32368615
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-335 and -543 suppress bone metastasis in prostate cancer via targeting endothelial nitric oxide synthase.
Fu Q; Liu X; Liu Y; Yang J; Lv G; Dong S
Int J Mol Med; 2015 Nov; 36(5):1417-25. PubMed ID: 26647850
[TBL] [Abstract][Full Text] [Related]
39. HEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of microRNA-145.
Guo W; Ren D; Chen X; Tu X; Huang S; Wang M; Song L; Zou X; Peng X
J Cell Biochem; 2013 Jul; 114(7):1606-15. PubMed ID: 23355420
[TBL] [Abstract][Full Text] [Related]
40. Thrombospondin-2 promotes prostate cancer bone metastasis by the up-regulation of matrix metalloproteinase-2 through down-regulating miR-376c expression.
Chen PC; Tang CH; Lin LW; Tsai CH; Chu CY; Lin TH; Huang YL
J Hematol Oncol; 2017 Jan; 10(1):33. PubMed ID: 28122633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
